Showing results (1-10 of 2,775) with videos related to
Sort By:
Pageof 278
Current Opinion in Ophthalmology|June 10, 2000
Neuroprotection: a new treatment modality for glaucoma?M Schwartz, E YolesEuropean Journal of Ophthalmology|May 7, 1999
Optic nerve degeneration and potential neuroprotection: implications for glaucomaM Schwartz, E YolesSurvey of Ophthalmology|March 11, 1998
Potential neuroprotective therapy for glaucomatous optic neuropathyE Yoles, M SchwartzActa Neurochirurgica. Supplement|July 1, 2005
Macrophages and dendritic cells treatment of spinal cord injury: from the bench to the clinicM Schwartz, E YolesExperimental Neurology|September 23, 1998
Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathiesE Yoles, M SchwartzArchives of Ophthalmology (Chicago, Ill. : 1960)|July 31, 1998
Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerveE Yoles, M SchwartzJournal of Neurotrauma|January 1, 1996
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomyE Yoles, M Belkin, M SchwartzJournal of Neurochemistry|February 7, 2001
Thrombin attenuation is neuroprotective in the injured rat optic nerveI Friedmann, E Yoles, M SchwartzJournal of Neurotrauma|October 23, 1997
NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crushE Yoles, S Muller, M SchwartzJournal of Neuroimmunology|October 5, 2001
T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous systemH Schori, E Yoles, M SchwartzPageof 278